Bristol Myers drugs may raise diabetes risk
The balance between the extent to which drugs help in the treatment of some conditions and their side effects can sometimes be an unsteady one. A new Canadian study has highlighted the potentially dangerous, even life-threatening, side effects of the Bristol Myers Squibb Company antibiotic Tequin.
Source:
www.diabetes.co.uk
Defeat Diabetes Foundation
Screening for coronary artery disease (CAD) in patients with Type 2 diabetes did not result in a significant reduction in the rate of myocardial infarctions (MI) or cardiac death compared with patients who were not screened, according to a study.
Source:
www.defeatdiabetes.org